NeuroSense Therapeutics
studies reveal potential effect of combination therapy | NeuroSense Therapeutics
Company
Deck Type
Sector
Industry
Deck date
December 2023
Slide
25 of 33
Similar slides by NeuroSense Therapeutics
See diffirences between slides (animation)
Investor Presentation
January 2024
studies reveal potential effect of combination therapy | NeuroSense Therapeutics
Related slides by other companies
Chimerix
Investor Presentation
August 2023
agonist distinct molecular target and efficacy profile relative to efficacy in preclinical models of advanced cancers tox studies complete potential to advance to partnerships established for early stage clinical trials with brown university and cancer center preclinical studies are ongoing to evaluate additional oncology indications and predictive for for clinical development pancreatic cancer model shows the potential of | Chimerix
Athira Pharma
Results
October 2022
a new potential therapy for disease | Athira Pharma
Avenue Therapeutics
IPO
October 2022
clinical studies demonstrate positive sedation and cognition effects | Avenue Therapeutics
Imara
Mergers and Acquisitions
October 2022
expected near term clinical milestones for parallel lead product candidates | Imara
Other recent decks by NeuroSense Therapeutics
See all presentations (3 decks)
Investor Presentation
January 2024
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io